Mimix™ Prostate Cancer Panel, cfDNA Reference Standard
The Prostate Cancer Panel cfDNA Reference Standard is a well characterized, cell line-derived control material manufactured under ISO:13485 that contains 17 variants (including 2 CNVs) across 9 genes clinically relevant to prostate cancer.
Clearance sale: Discounted pricing on selected cfDNA inventory. Limited availability.*
*This pricing promotion is only valid on selected products and while stocks last. Not valid in Italy and China. The promotion cannot be combined with any other promotions, discounts, or offers. Conditions of the promotions may change, and Revvity may void, change, cancel, suspend, or amend this promotion without notice.